Price$11.37+3.04 (+36.49%)
2026-01-292026-05-04
News · 26 weeks44+300%
2025-12-072026-05-31
Mix2790d
- Insider16(59%)
- Other5(19%)
- SEC Filings5(19%)
- Leadership1(4%)
Latest news
25 items- SECAmendment: Ekso Bionics Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K/A - ChronoScale Corp (0001549084) (Filer)
- INSIDERDirector Cummins Wes was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Miller Douglas S was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Benson Ella G. was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Nottenburg Richard N was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERChief Financial Officer Wong Jerome was granted 40,000 shares, increasing direct ownership by 161% to 64,771 units (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Davis Scott G. was granted 109,357 shares, increasing direct ownership by 139% to 188,134 units (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERDirector Clancy William M was granted 200,000 shares (SEC Form 4)4 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by Ekso Bionics Holdings Inc.3 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by Ekso Bionics Holdings Inc.3 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by new insider Chen Ying Cenly3 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERNew insider Applied Digital Corp. claimed ownership of 139,528,227 shares (SEC Form 3)3 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by new insider Miller Douglas S3 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by Ekso Bionics Holdings Inc.3 - ChronoScale Corp (0001549084) (Issuer)
- INSIDERSEC Form 3 filed by new insider Benson Ella G.3 - ChronoScale Corp (0001549084) (Issuer)
- SECSEC Form SCHEDULE 13D filed by Ekso Bionics Holdings Inc.SCHEDULE 13D - ChronoScale Corp (0001549084) (Subject)
- PRChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute GrowthDALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ:CHRN), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced the appointment of Cenly Chen as Chief Executive Officer and a member of the Company's Board of Directors. Ms. Chen brings more than two decades of experience scaling enterprise infrastructure and high-performance computing platforms in global markets. She most recently served as Chief Growth Officer, Senior Vice President & Managing Director at Super Micro Computer, Inc. (NASDAQ:SMCI), where she led global growth initiatives across AI and enterprise infrastructure markets. "We believe the mar
- SECAmendment: Ekso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K/A - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
- SECEkso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
- SECSEC Form 10-Q filed by Ekso Bionics Holdings Inc.10-Q - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
- SECAmendment: SEC Form 10-K/A filed by Ekso Bionics Holdings Inc.10-K/A - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
- SECSEC Form DEF 14C filed by Ekso Bionics Holdings Inc.DEF 14C - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
- SECSEC Form PRER14C filed by Ekso Bionics Holdings Inc.PRER14C - EKSO BIONICS HOLDINGS, INC. (0001549084) (Filer)
- INSIDERSEC Form 4 filed by Jones Jason C4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
- INSIDERSEC Form 4 filed by Wong Jerome4 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)
EKSO FAQ
5 questionsWhat does Ekso Bionics Holdings Inc. do?
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock...Where does EKSO stock trade?
Ekso Bionics Holdings Inc. (EKSO) is listed on NASDAQ.What sector and industry is EKSO in?
Ekso Bionics Holdings Inc. operates in the Industrials sector, Industrial Machinery/Components industry.What companies are similar to EKSO?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), ETN (Eaton Corporation PLC), DE (Deere & Company). Compare EKSO side-by-side with any of them on Quantisnow.How can I track EKSO on Quantisnow?
Quantisnow aggregates Ekso Bionics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EKSO to receive live email and push alerts on every new disclosure.